Monte Rosa Therapeutics's total assets for Q3 2023 were $252.10M, a decrease of -9.52% from the previous quarter. GLUE total liabilities were $67.58M for the fiscal quarter, a 4.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.